New funding brings total capital raised to $135 million Molecular gates offer the convenience of a pill with potential for superior efficacy through a novel mechanism that eliminates disease-causing proteins at their source Financing will support clinical development of differentiated small molecule therapies targeting high-value inflammatory and neurological disease proteins BRISBANE, Calif., Nov. 13, 2025 […]

Windfall Bio's FOUNDATION Outperforms Traditional Non-synthetic Fertilizer in New Field Trial GlobeNewswire November 13, 2025 Lettuce field trial confirms FOUNDATION's superior agronomic performance over conventional feather meal, delivering a 23-34% yield boost On par with premium soy hydrolysate, FOUNDATION provides growers with a cost-effective and high-performing alternative that increases profitability A nitrogen- and amino acid-rich

(NASDAQ:CTMX), SOUTH SAN FRANCISCO, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced that Sean McCarthy, D.Phil., chief executive officer and chairman, will participate in a fireside chat at the Jefferies Global Healthcare Conference in London on Thursday, November 20,

Roundtable CEO James Heckman to Host Virtual Investor Event on Thursday, November 20 Ahead of Merger with RYVYL GlobeNewswire November 13, 2025 SAN DIEGO, CA, Nov. 13, 2025 (GLOBE NEWSWIRE) — Roundtable (the “Company”) CEO James Heckman today announced that ahead of Roundtable's expected merger with RYVYL Inc. (NASDAQ: RVYL), the Company will host a

GenoSafe strengthens its leadership in analytical expertise with the opening of new GMP-compliant laboratories to support the advanced therapies sector Evry-Courcouronnes, France, November 16th, 2025 – GenoSafe, the French Contract Research Organization (CRO) specialized in the characterization and evaluation of advanced therapy medicinal products (ATMPs), today inaugurates its new 1,200 m(2) laboratories at the Genopole

Tether-Backed OOBIT Token Trading Live on Kraken; VCI Global Reports US$109.8 Million Unrealized Gain from Initial US$50 Million Digital-Treasury Deployment VCIG Acquired 250 Million OOB Tokens at US$0.20 Per Token Under Its US$100 Million Digital-Treasury Framework. As of 12.00 A.M. ET, OOB Traded at Approximately US$640 Million Fully Diluted Valuation on Kraken GlobeNewswire November 13,

MeiraGTx Reports Third Quarter 2025 Financial and Operational Results GlobeNewswire November 13, 2025 Entered into broad strategic collaboration with Eli Lilly and Company (“Lilly”) in the area of ophthalmology, granting Lilly worldwide exclusive rights to the Company's AAV-AIPL1 program for treatment of one of the most severe inherited retinopathies, Leber congenital amaurosis 4 (LCA4) Released

Geleen, November 13th, 2025. Matisse Pharmaceuticals B.V., a clinical stage company developing a medicinal product for the treatment of sepsis, today announced top line results from its phase 1 study evaluating the safety, tolerability & pharmacokinetics of a 120-hour intravenous (IV) continuous infusion with its lead compound M6229. The study met its primary objectives, showing

BAK Battery Unveils RoPower Series to Fuel the Next Generation of Humanoid Robots GlobeNewswire November 13, 2025 SHENZHEN, China, Nov. 13, 2025 (GLOBE NEWSWIRE) — As humanoid robots move from factory prototypes to real-world deployment, power innovation has become the decisive factor shaping their future. This week, BAK Battery announced the launch of its new

Silicon Motion to Attend Upcoming Investor Conferences GlobeNewswire November 13, 2025 TAIPEI, Taiwan and MILPITAS, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) — Silicon Motion Technology Corporation (NasdaqGS: SIMO), a global leader in designing and marketing NAND flash controllers for solid state storage devices, today announced that it will participate in the following upcoming conferences: JPMorgan Global TMT